TIAA CREF Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $103M | Buy |
6,586,071
+550,496
| +9% | +$8.63M | 0.07% | 249 |
|
|
2018
Q4 | $93.1M | Sell |
6,035,575
-299,874
| -5% | -$4.62M | 0.07% | 256 |
|
|
2018
Q3 | $136M | Buy |
6,335,449
+264,693
| +4% | +$5.7M | 0.09% | 212 |
|
|
2018
Q2 | $148M | Buy |
6,070,756
+823,633
| +16% | +$20M | 0.1% | 198 |
|
|
2018
Q1 | $89.7M | Buy |
5,247,123
+3,859,347
| +278% | +$66M | 0.06% | 298 |
|
|
2017
Q4 | $26.3M | Buy |
1,387,776
+226,110
| +19% | +$4.28M | 0.02% | 664 |
|
|
2017
Q3 | $20.4M | Buy |
1,161,666
+495,592
| +74% | +$8.72M | 0.01% | 753 |
|
|
2017
Q2 | $22.1M | Buy |
666,074
+33,938
| +5% | +$1.13M | 0.02% | 706 |
|
|
2017
Q1 | $20.3M | Sell |
632,136
-384,461
| -38% | -$12.3M | 0.01% | 739 |
|
|
2016
Q4 | $36.9M | Buy |
1,016,597
+578,826
| +132% | +$21M | 0.03% | 525 |
|
|
2016
Q3 | $20.1K | Sell |
437,771
-1,637,576
| -79% | -$75.3K | 0.01% | 777 |
|
|
2016
Q2 | $104M | Sell |
2,075,347
-409,949
| -16% | -$20.6M | 0.08% | 258 |
|
|
2016
Q1 | $133M | Buy |
2,485,296
+843,358
| +51% | +$45.1M | 0.1% | 197 |
|
|
2015
Q4 | $108M | Buy |
1,641,938
+1,163,133
| +243% | +$76.3M | 0.08% | 249 |
|
|
2015
Q3 | $27M | Buy |
478,805
+108,800
| +29% | +$6.14M | 0.02% | 640 |
|
|
2015
Q2 | $21.9M | Hold |
370,005
| – | – | 0.02% | 758 |
|
|
2015
Q1 | $23.1M | Sell |
370,005
-34,000
| -8% | -$2.12M | 0.02% | 727 |
|
|
2014
Q4 | $23.2M | Hold |
404,005
| – | – | 0.02% | 711 |
|
|
2014
Q3 | $21.7M | Buy |
404,005
+85,326
| +27% | +$4.59M | 0.02% | 737 |
|
|
2014
Q2 | $16.7M | Sell |
318,679
-26,000
| -8% | -$1.36M | 0.01% | 858 |
|
|
2014
Q1 | $18.2M | Buy |
344,679
+60,000
| +21% | +$3.17M | 0.01% | 826 |
|
|
2013
Q4 | $11.4M | Sell |
284,679
-619,986
| -69% | -$24.8M | 0.01% | 1068 |
|
|
2013
Q3 | $34.2M | Sell |
904,665
-305,828
| -25% | -$11.6M | 0.03% | 569 |
|
|
2013
Q2 | $47.5M | Buy |
+1,210,493
| New | +$47.5M | 0.04% | 461 |
|